Literature DB >> 12463443

Psoriatic arthritis--pathogenesis and epidemiology.

D J Veale1, O FitzGerald.   

Abstract

Psoriatic arthritis (PsA), recognised for over 100 years, is common representing the second most frequent diagnostic category after RA and occurring in up to 10% of patients with skin psoriasis. The pathogenic connection between psoriasis and arthritis is not yet clear although our understanding of the mechanisms of disease has progressed significantly in recent years. Factors including immunogenetics, infection, autoimmunity, angiogenesis, trauma and the nervous system are implicated in the pathogenesis of PsA. Organ involvement is largely restricted to the connective tissue of the skin and joints, including both the synovial tissue and sites of entheseal attachment. This restricted inflammatory response suggests that either a common antigen driving the immune response or that antigenic proteins or cells are present at these sites only having migrated the or arising de novo. The epidemiology of Psoriasis has been extensively examined since the 1960's, however there have been few large epidemiological studies of PsA. In addition, the lack of diagnostic criteria for the diagnosis of PsA until 1973, and the diffuse clinical manifestations of this condition have hindered meaningful conclusion regarding the epidemiology of this form of arthritis.

Entities:  

Mesh:

Year:  2002        PMID: 12463443

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  [Diagnosis and therapy of early psoriatic arthritis].

Authors:  M Köhm; F Behrens
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

Review 2.  [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

3.  Sacroiliac joint involvement in psoriasis.

Authors:  Cahit Kaçar; Ilhan Sezer; Hilal Kocabaş; Hasan Fatih Cay; Can Cevikol; Erkan Alpsoy; Meltem Alkan Melikoğlu; Ayşe Akman
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

Review 4.  Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.

Authors:  Aisha Q Butt; Angela McArdle; David S Gibson; Oliver FitzGerald; Stephen R Pennington
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

Review 5.  Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.

Authors:  Angela McArdle; Stephen Pennington; Oliver FitzGerald
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

6.  Ultrasound and psoriatic arthritis - Review of the literature and general considerations.

Authors:  F M Solivetti; G M Andreoli; D Bacaro
Journal:  J Ultrasound       Date:  2007-05-25

7.  Negative and positive life experiences in patients with psoriatic arthritis.

Authors:  Edita Simonić; Sandra Peternel; Liliana Stojnić-Soša; Ika Rončević-Gržeta; Larisa Prpić-Massari; Dražen Massari; Darinka Periša; Leo Cabrijan; Marija Kaštelan
Journal:  Rheumatol Int       Date:  2012-11-21       Impact factor: 2.631

8.  Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation.

Authors:  Heike C Hawerkamp; Alina Domdey; Lisa Radau; Philipp Sewerin; Péter Oláh; Bernhard Homey; Stephan Meller
Journal:  Arthritis Res Ther       Date:  2021-05-21       Impact factor: 5.156

9.  Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Authors:  Sarah L Jongbloed; M Cristina Lebre; Alasdair R Fraser; J Alastair Gracie; Roger D Sturrock; Paul P Tak; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 10.  Sacroiliac joint pain as an important element of psoriatic arthritis diagnosis.

Authors:  Agnieszka Krawczyk-Wasielewska; Elżbieta Skorupska; Włodzimierz Samborski
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.